News Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Staff June 25, 2022 Iframe sync Post navigation Previous: Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical UpdateNext: Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASL’s International Liver Congress™ More Stories Disability Healthcare News Pharmaceutical A Christmas Message to the DEA’s Diversion Anti Marijuana Cabal Staff December 26, 2025 Brain Cancer News Pharmaceutical Kanazawa University research: High-speed AFM imaging reveals how brain enzyme forms dodecameric ring structure Staff December 26, 2025 News Arspura Showcases a New Standard for Healthy Kitchen Living at CES 2026 Staff December 25, 2025
